Soltys P J, Zydney A, Leypoldt J K, Henderson L W, Ofsthun N J
Renal Division, Baxter Healthcare Corp., McGaw Park, IL 60085-6730, USA.
Kidney Int. 2000 Aug;58(2):818-28. doi: 10.1046/j.1523-1755.2000.00231.x.
Potential backfiltration of cytokine-inducing material is a clinical concern during hemodialysis conducted with high-flux membranes. Novel hollow-fiber membranes were developed that had asymmetric convective solute transport properties, aimed at reducing the passage of potentially harmful molecules from dialysate to blood, while maintaining the desired fluid and solute movement from blood to dialysate.
Sieving coefficient as a function of molecular weight was measured in vitro using polydisperse dextrans. Measurements were conducted using two different flat-sheet membranes in series or using hollow fiber membranes having two integrally formed skin layers. Based on measured experimental parameters, model calculations simulated the performance of a clinical-scale dialyzer containing these new membranes versus that of a commercially available high-flux dialyzer.
Asymmetric convective solute transport was demonstrated using both commercial flat-sheet and newly developed hollow-fiber membranes. For two flat-sheet membranes in series, the extent of asymmetric transport was dependent on the order in which the solution was filtered through the membranes. For the hollow-fiber membranes, the nominal molecular weight cut-off was 20 kD in the blood-to-dialysate direction and 13 kD in the dialysate-to-blood direction. For this membrane, model calculations predict that clearance of a beta2-microglobulin-sized molecule (11,800 D) would be significantly greater from blood to dialysate than in the reverse direction, even under conditions of zero net ultrafiltration.
A novel hollow-fiber dialysis membrane was developed that allows greater convective solute transport from blood to dialysate than from dialysate to blood.
在使用高通量膜进行血液透析期间,细胞因子诱导物质的潜在反向滤过是一个临床关注点。研发了具有不对称对流溶质转运特性的新型中空纤维膜,旨在减少潜在有害分子从透析液进入血液的通过量,同时保持所需的液体和溶质从血液到透析液的移动。
使用多分散葡聚糖在体外测量筛分系数作为分子量的函数。测量使用两个串联的不同平板膜或具有两个整体形成的皮层的中空纤维膜进行。基于测量的实验参数,模型计算模拟了包含这些新膜的临床规模透析器与市售高通量透析器的性能。
使用商业平板膜和新开发的中空纤维膜均证明了不对称对流溶质转运。对于两个串联的平板膜,不对称转运的程度取决于溶液通过膜的过滤顺序。对于中空纤维膜,在血液到透析液方向的标称截留分子量为20 kD,在透析液到血液方向为13 kD。对于这种膜,模型计算预测,即使在零净超滤条件下,β2-微球蛋白大小的分子(11,800 D)从血液到透析液的清除率将明显高于反向清除率。
研发了一种新型中空纤维透析膜,其允许从血液到透析液的对流溶质转运比从透析液到血液的对流溶质转运更大。